I want to eliminate the feeling of 'I wish I had known sooner.' Making pregnancy a choice, not a matter of luck. #AprilDream
TL Genomics is working to transform the fertility landscape by providing scientific data on cellular aging, allowing women to make informed decisions about their reproductive health. Through their 'MyAge F' test, they aim to move away from relying on luck and toward a future where pregnancy planning is based on individual biological insights.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 18:00
- 🔍 Collected: April 1, 2026 at 09:36
- 🤖 AI Analyzed: June 2, 2026 at 13:02 (1491h 26m after Collected)
TL Genomics Inc. (Fujisawa City, Kanagawa Prefecture; Representative Director: Tomohiro Kubo) supports the PR TIMES "April Dream" project and shares the following dream:
To create a society where, when people start thinking about pregnancy, they no longer have to regret, "I wish I had known sooner." We will realize a future where pregnancy can be chosen based on information, not luck.
【When you finally realize it, time has already passed — The reality many women face】
Approximately one in 4.4 couples has experienced fertility testing or treatment, and about one in 2.5 couples worries that they "might be infertile" (National Institute of Population and Social Security Research). Even so, many women share the experience of "missing the timing to get tested" or "realizing that time had passed before they knew it."
The problem is not a lack of will or effort. It is a structural issue where "the information necessary for decision-making simply did not exist."
Conventional AMH tests measure the "number" of eggs. However, while some people cannot conceive even with many eggs, others conceive naturally with few. There has always been something that cannot be measured by "number" alone that remained invisible.
[Image Caption: "Conceiving naturally is best," "It sounds painful and scary," "It seems expensive" — The reasons for hesitating to pursue in vitro fertilization are never a sign of weakness. Time simply slips away while lacking the information needed to make a decision. That is the reality many women face.]
【A new indicator revealed by science】
Through joint research with the National Cerebral and Cardiovascular Center and Osaka Metropolitan University, TL Genomics analyzed data from 500 women, primarily in their 30s. The results revealed that the "degree of cellular aging" can serve as an indicator of pregnancy potential. These findings were published in the international reproductive medicine journal "Reproductive BioMedicine Online" in February 2026.
The three insights gained from the research are as follows:
① AMH (egg count) and cellular aging provide different information
We confirmed that there is no correlation between AMH levels and indicators of cellular aging. This suggests that individual differences, which cannot be seen by egg count alone, may be explained by the degree of biological aging.
② As cellular aging progresses, the success rate of natural conception tends to decline
The association with pregnancy success rates was quantitatively confirmed using biological indicators at the cellular level, rather than chronological age.
③ Even if cellular aging has progressed, there is no significant difference in the success rate of in vitro fertilization
This finding suggests that by switching treatment strategies at an early stage, it is possible to maintain pregnancy potential. In other words, science shows that it is not "age" or "egg count," but the current state of the body that holds significant meaning for decision-making.
【What "MyAge F" wants to deliver】
[Image Caption: In many cases, it takes an average of 2 to 3 years from starting fertility efforts to reaching in vitro fertilization. By grasping one's pregnancy potential early through the fertility test "MyAge F," it is possible to move up the timing of treatment decisions and significantly change life plans for the first and second child.]
The fertility test "MyAge F" (a research-use test) measures cellular aging using changes in the X chromosome in the blood as an indicator, visualizing the potential for natural conception. You can take the test simply by collecting a blood sample at home and mailing it in (25,600 yen including tax), and results are delivered in about 10 days.
This test does not aim to "tell you the correct answer." It aims to ensure that every choice—whether to aim for natural conception, proceed to in vitro fertilization early, or consider egg freezing—is made based on the evidence of one's own physical condition, rather than intuition or anxiety.
Representative Tomohiro Kubo's research originated from his experience with his wife's high-risk pregnancy. That experience led to his awareness of the problem: "I want to use technology to eliminate the situation where time passes without having the necessary information."
【Our Dream】
We want to increase the number of women who can say, "I want to choose based on knowing my current self." We want a society where the desire to have children is not pushed to the back burner or left to luck. TL Genomics will continue to work toward this realization through science and technology. To be able to know the state of one's body at the stage when one begins to think about pregnancy. And based on that, to be able to make choices that fit one's life plan. Implementing such an "information infrastructure" in society is our mission.
* "April Dream" is a project by PR TIMES where companies share the dreams they hope to achieve in the future on April 1st. We are seriously aiming to realize this dream.
【MyAge F Test Overview】
[Table: Official Name: Fertility Test "MyAge F" (Research-use test); Test Method: SinChro™ method (Cellular aging measurement using X-chromosome loss (LOX) as an indicator); Testing Method: Mail-in self-blood collection kit (individual application) / via partner clinics; Price: 25,600 yen (tax included, individual application); Results Reporting: Approx. 10 days from sample arrival; Application: https://tlgenomics.com/my-age/]
【Company Overview】
Company Name: TL Genomics Inc. (URL: https://tlgenomics.com)
Representative: Tomohiro Kubo, Representative Director
Address: Shonan Fujisawa Incubation LABO #3, 2020-5 Endo, Fujisawa City, Kanagawa Prefecture
Established: January 2015
Business Description: Development of tests and diagnostic agents related to bone marrow transplantation; Development and sales of disease risk and fertility tests through chromosome analysis (MyAge, MyAge F); Other medical-related services
【Contact Information】
TL Genomics Inc. Public Relations / Segawa Email: asegawa@tl-genomics.com
To create a society where, when people start thinking about pregnancy, they no longer have to regret, "I wish I had known sooner." We will realize a future where pregnancy can be chosen based on information, not luck.
【When you finally realize it, time has already passed — The reality many women face】
Approximately one in 4.4 couples has experienced fertility testing or treatment, and about one in 2.5 couples worries that they "might be infertile" (National Institute of Population and Social Security Research). Even so, many women share the experience of "missing the timing to get tested" or "realizing that time had passed before they knew it."
The problem is not a lack of will or effort. It is a structural issue where "the information necessary for decision-making simply did not exist."
Conventional AMH tests measure the "number" of eggs. However, while some people cannot conceive even with many eggs, others conceive naturally with few. There has always been something that cannot be measured by "number" alone that remained invisible.
[Image Caption: "Conceiving naturally is best," "It sounds painful and scary," "It seems expensive" — The reasons for hesitating to pursue in vitro fertilization are never a sign of weakness. Time simply slips away while lacking the information needed to make a decision. That is the reality many women face.]
【A new indicator revealed by science】
Through joint research with the National Cerebral and Cardiovascular Center and Osaka Metropolitan University, TL Genomics analyzed data from 500 women, primarily in their 30s. The results revealed that the "degree of cellular aging" can serve as an indicator of pregnancy potential. These findings were published in the international reproductive medicine journal "Reproductive BioMedicine Online" in February 2026.
The three insights gained from the research are as follows:
① AMH (egg count) and cellular aging provide different information
We confirmed that there is no correlation between AMH levels and indicators of cellular aging. This suggests that individual differences, which cannot be seen by egg count alone, may be explained by the degree of biological aging.
② As cellular aging progresses, the success rate of natural conception tends to decline
The association with pregnancy success rates was quantitatively confirmed using biological indicators at the cellular level, rather than chronological age.
③ Even if cellular aging has progressed, there is no significant difference in the success rate of in vitro fertilization
This finding suggests that by switching treatment strategies at an early stage, it is possible to maintain pregnancy potential. In other words, science shows that it is not "age" or "egg count," but the current state of the body that holds significant meaning for decision-making.
【What "MyAge F" wants to deliver】
[Image Caption: In many cases, it takes an average of 2 to 3 years from starting fertility efforts to reaching in vitro fertilization. By grasping one's pregnancy potential early through the fertility test "MyAge F," it is possible to move up the timing of treatment decisions and significantly change life plans for the first and second child.]
The fertility test "MyAge F" (a research-use test) measures cellular aging using changes in the X chromosome in the blood as an indicator, visualizing the potential for natural conception. You can take the test simply by collecting a blood sample at home and mailing it in (25,600 yen including tax), and results are delivered in about 10 days.
This test does not aim to "tell you the correct answer." It aims to ensure that every choice—whether to aim for natural conception, proceed to in vitro fertilization early, or consider egg freezing—is made based on the evidence of one's own physical condition, rather than intuition or anxiety.
Representative Tomohiro Kubo's research originated from his experience with his wife's high-risk pregnancy. That experience led to his awareness of the problem: "I want to use technology to eliminate the situation where time passes without having the necessary information."
【Our Dream】
We want to increase the number of women who can say, "I want to choose based on knowing my current self." We want a society where the desire to have children is not pushed to the back burner or left to luck. TL Genomics will continue to work toward this realization through science and technology. To be able to know the state of one's body at the stage when one begins to think about pregnancy. And based on that, to be able to make choices that fit one's life plan. Implementing such an "information infrastructure" in society is our mission.
* "April Dream" is a project by PR TIMES where companies share the dreams they hope to achieve in the future on April 1st. We are seriously aiming to realize this dream.
【MyAge F Test Overview】
[Table: Official Name: Fertility Test "MyAge F" (Research-use test); Test Method: SinChro™ method (Cellular aging measurement using X-chromosome loss (LOX) as an indicator); Testing Method: Mail-in self-blood collection kit (individual application) / via partner clinics; Price: 25,600 yen (tax included, individual application); Results Reporting: Approx. 10 days from sample arrival; Application: https://tlgenomics.com/my-age/]
【Company Overview】
Company Name: TL Genomics Inc. (URL: https://tlgenomics.com)
Representative: Tomohiro Kubo, Representative Director
Address: Shonan Fujisawa Incubation LABO #3, 2020-5 Endo, Fujisawa City, Kanagawa Prefecture
Established: January 2015
Business Description: Development of tests and diagnostic agents related to bone marrow transplantation; Development and sales of disease risk and fertility tests through chromosome analysis (MyAge, MyAge F); Other medical-related services
【Contact Information】
TL Genomics Inc. Public Relations / Segawa Email: asegawa@tl-genomics.com